Figure 1
From: Lee mortality index as comorbidity measure in patients undergoing radical cystectomy
Competing risk analysis stratified by the modified Lee mortality index illustrating the dose–response relationship between the Lee mortality index and competing mortality and the absence of a relationship with bladder cancer mortality after radical cystectomy. Five- and ten-year competing mortality rates with 95% confidence intervals for the different Lee mortality index subgroups are shown in the table below.